Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.
Yanjun ZhongLishu ZhaoGuobao WuChunhong HuChenfang WuMin XuHaiyun DongQuan ZhangGuyi WangBo YuJianlei LvChao WuSiye ZhangChenghui CaoLong ShuYue PanXianling LiuFang WuPublished in: The Journal of international medical research (2020)
There was no significant association of ACEI/ARB use with mortality in severe COVID-19 patients with hypertension. These findings support the continuation of ACEI/ARB therapy for such patients.